Incyte Q1 Results Top Estimates

RTTNews | 941 gün önce
Incyte Q1 Results Top Estimates

(RTTNews) - Incyte Corp. (INCY) on Tuesday reported net income of $161.43 million or $0.72 per share for the first quarter, up from $149.46 million or $0.67 per share in the prior-year quarter.

Excluding items, adjusted net income for the quarter was $1.01 per share, compared to $0.80 per share in the year-ago quarter.

Total revenues for the quarter rose 29 percent to $911.40 million from $705.71 million in the same quarter last year.

On average, analysts polled by Thomson Reuters expected the company to report earnings of $0.76 per share on revenues of $818.49 million for the quarter. Analysts' estimates typically exclude special items.

Looking ahead to fiscal 2022, Incyte now projects Jakafi net product revenue in a range of $2.36 billion to $2.40 billion. Other Hematology/Oncology net product revenues are projected between $210 million and $240 million.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

Etiketler: INCY
read more
Incyte Q4 Adj EPS Misses Estimates, But Revenues Top

Incyte Q4 Adj EPS Misses Estimates, But Revenues Top

Incyte Corp. (INCY) on Tuesday reported net income of $201.10 million or $0.89 per share for the fourth quarter, sharply higher than $28.46 million or $0.13 per share in the prior-year quarter.
RTTNews | 381 gün önce
Incyte Says FDA Issued CRL For Ruxolitinib Extended-release Tablets

Incyte Says FDA Issued CRL For Ruxolitinib Extended-release Tablets

Incyte Corp. (INCY) announced Friday that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for ruxolitinib extended-release (XR) tablets, a JAK1/JAK2 inhibitor, for once-daily (QD) use in the treatment of certain types of myelofibrosis (MF), polycythemia vera (PV) and graft-versus-host disease (GVHD).
RTTNews | 707 gün önce
TSX Ends More Than 1% Up

TSX Ends More Than 1% Up

After a weak start and a subsequent recovery, the Canadian market slipped into negative territory around early afternoon on Friday, but gained in strength after that with stocks from industrials, financials, utilities and consumer staples attracting buyers.
RTTNews | 7s 9 dakika önce
Dollar Rises Against Major Counterparts

Dollar Rises Against Major Counterparts

The U.S. dollar climbed higher on Friday, extending gains from the previous session following U.S. President Donald Trump's announcement that the 25% tariffs on Canada and Mexico, and an additional 10% on China, will take effect early next week.
RTTNews | 7s 43 dakika önce
German Inflation Steady At 2.3% In February

German Inflation Steady At 2.3% In February

Consumer price inflation in Germany was unchanged in February, while the core price growth slowed as the cost of food increased strongly, preliminary data from the statistical office Destatis showed on Friday.
RTTNews | 10s 11 dakika önce
Canadian Market Modestly Higher In Cautious Trade

Canadian Market Modestly Higher In Cautious Trade

The Canadian benchmark S&P/TSX Composite Index is modestly higher in late afternoon trades on Friday with stocks turning in a mixed performance. Worries about U.S. tariffs and their potential impact on global economic growth appear to be weighing on sentiment. Investors are also digesting the nation's GDP report and U.S. PCE reading.
RTTNews | 10s 24 dakika önce
Pound Retreats Amid Risk Aversion

Pound Retreats Amid Risk Aversion

The pound pulled back against its most major counterparts in the New York session on Friday, as risk sentiment dampened after a meeting between President Donald Trump and Ukrainian President Volodymyr Zelenskyy devolved into a shouting match.
RTTNews | 10s 27 dakika önce
Swiss Market Ends On Firm Note

Swiss Market Ends On Firm Note

After a weak start and a subsequent recovery, the Swiss market struggled for direction till mid afternoon on Friday, but gained in strength thanks to some brisk buying at several counters in last ninety minutes of the day's session.
RTTNews | 11s 26 dakika önce